company

Tessel Bio

Tessel Bio is a company that applies AI to drug development. It announced Sesame, AI for generative chemistry, on 24 Jun 2026.

tessel.bio

Key facts

Product announcement: Announcing Sesame: Frontier AI for generative chemistry (24 Jun 2026)source
Collaboration: Tessel and Sanofi collaborate on AI for target discovery (05 Jan 2026)source
Collaboration: Tessel and Century Health collaborate to accelerate drug development (18 Dec 2025)source
Award: Tessel awarded up to $4.2M by ARPA-H (10 Dec 2025)source

WYDE coverage of Tessel Bio

WYDE Newsroom has published one article about Tessel Bio, on Jun 29, 2026. Tessel Bio is the subject of 1 story. The most recent is Tessel Bio Releases Sesame, a Generative Chemistry Model That Fills Any Protein Pocket.

Tessel Bio Releases Sesame, a Generative Chemistry Model That Fills Any Protein Pocket

Tessel Bio released Sesame, a diffusion-based generative chemistry model that designs drug-like molecules in any protein pocket, de novo or from a chemist's scaffold, with a preprint on arXiv.

Jun 29, 2026 · 2 min read · Subject of the story

Sources

Tessel Biosciences - home page news list

Track the institutions that move money.

Data-driven coverage, every week.